Yahoo · Feb 11, 2026
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Asian equities traded in the US as American depositary receipts were tracking higher Wednesday morni
YI
NASDAQ · YI
111, Inc.
Healthcare · Medical - Pharmaceuticals
$3.15
Up+$0.01 (+0.32%)
Updated Oct 10, 2026, 5:48 PM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 33.2M
- P/E ratio
- -3.16
- Dividend yield
- 0.00%
- 52-week range
- $2.48 – $11.17
- Volume
- 6.09K
- Avg. volume
- 16.3K
Price performance · YI
YI price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
YI closed at $3.15 after 21 trading sessions, down 12.25% for the selected period.
- Last close
- $3.15
- Period change
- -12.25%
- Period low
- $3.09
- Period high
- $3.71
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $3.15 | $3.16 | $3.15 | $3.15 | 6.09K |
| Oct 8, 2026 | $3.12 | $3.22 | $3.07 | $3.14 | 3.02K |
| Oct 7, 2026 | $3.15 | $3.22 | $3.09 | $3.15 | 18.83K |
| Oct 6, 2026 | $3.14 | $3.245 | $3.09 | $3.09 | 12.8K |
| Oct 5, 2026 | $3.21 | $3.21 | $3.15 | $3.15 | 4.55K |
| Oct 2, 2026 | $3.26 | $3.5728 | $3.21 | $3.22 | 15.48K |
| Oct 1, 2026 | $3.47 | $3.47 | $3.26 | $3.305 | 9.69K |
| Sep 30, 2026 | $3.49 | $3.7699 | $3.30 | $3.425 | 17.91K |
| Sep 29, 2026 | $3.50 | $3.59 | $3.50 | $3.50 | 10.47K |
| Sep 28, 2026 | $3.904 | $3.904 | $3.52 | $3.52 | 17.97K |
| Sep 25, 2026 | $3.60 | $3.60 | $3.60 | $3.60 | 584.18 |
| Sep 24, 2026 | $3.59 | $3.59 | $3.59 | $3.59 | 644.58 |
| Sep 23, 2026 | $3.67 | $3.85 | $3.52 | $3.71 | 19.47K |
| Sep 22, 2026 | $3.79 | $3.87 | $3.50 | $3.55 | 28.28K |
| Sep 21, 2026 | $3.51 | $4.08 | $3.50 | $3.645 | 26.93K |
| Sep 18, 2026 | $3.56 | $3.61 | $3.50 | $3.60 | 14.26K |
| Sep 17, 2026 | $3.49 | $3.60 | $3.37 | $3.54 | 81.2K |
| Sep 16, 2026 | $3.28 | $3.50 | $3.28 | $3.38 | 11.13K |
| Sep 15, 2026 | $3.32 | $3.5002 | $3.32 | $3.49 | 10.02K |
| Sep 14, 2026 | $3.58 | $3.60 | $3.34 | $3.50 | 19.07K |
| Sep 11, 2026 | $3.30 | $3.65 | $3.20 | $3.5898 | 35.01K |
Latest YI news
The latest Smart Investors Daily articles mentioning YI.
Stock researchCompany · Overview
Company
Market Activity
Research & News
YI research
Overview
Company profile and research snapshot.
Company profile
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Feb 4, 2026
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
Asian equities traded in the US as American depositary receipts were slightly higher Wednesday morni
defenseworld.net · Nov 27, 2025
Head to Head Contrast: Privia Health Group (NASDAQ:PRVA) & 111 (NASDAQ:YI)
Privia Health Group (NASDAQ: PRVA - Get Free Report) and 111 (NASDAQ: YI - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Institutional and Insider Ownership 94.5% of Privia Health
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
